Regulatory categories of probiotics across the globe: A review representing existing and recommended categorization

Indian Journal of Medical Microbiology

Volumn 33, Issue , 2015, Pages S2-S10

  Arora, M ^a,b   Baldi, A ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b I K GUJRAL PUNJAB TECHNICAL UNIVERSITY   (India)

Author keywords

Generally recognized as safe; Probiotic categories; Probiotics; Regulatory bodies; Therapeutic benefits

Indexed keywords

BIOLOGICAL PRODUCT; NUTRACEUTICAL; PROBIOTIC AGENT;

AUSTRALIA; BRAZIL; CANADA; CHINA; CLASSIFICATION; DENMARK; DIET SUPPLEMENTATION; DRUG LEGISLATION; DRUG SAFETY; EUROPE; FINLAND; FOOD AND DRUG ADMINISTRATION; FOOD SAFETY; FUNCTIONAL FOOD; HEALTH FOOD; HUMAN; INDIA; JAPAN; MALAYSIA; MARKETING; NEW ZEALAND; NOMENCLATURE; REVIEW; SWEDEN; UNITED STATES; HEALTH; LEGISLATION AND JURISPRUDENCE; PUBLIC HEALTH;

DIETARY SUPPLEMENTS; GLOBAL HEALTH; HUMANS; PROBIOTICS; PUBLIC HEALTH;

EID: 84923351295     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.150868     Document Type: Review

References (45)

1. Molle t B, Rowland I. Functional foods: At the frontier between food and pharma. Curr Opin Biotechnol 2002;13:483-5.
2. Menrad K. Market and marketing of functional food in Europe. J Food Eng 2003;56:81-8.
3. Roberfroid MB. Concepts and strategy of functional food science: The European perspective. Am J Clin Nutr 2000;71:1660-4S.
4. Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br J Nutr 2002;88:S39-49.
5. Galdeano CM, Perdigón G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 2006;13:219-26.
6. Saikali J, Picard C, Freitas M, Holt P. Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer 2004;49:14-24.
7. Jones K. Probiotics: Preventing antibiotic-associated diarrhea. J Spec Pediatr Nurs 2010;15:160-2.
8. Kumar M, Kumar R, Poovai PD, Kalaichelvan PT. Probiotics and multitude of health benefits. J Res Bio 2012;2:102-13.
9. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006;100:1171-85.
10. FAO/WHO. Report of a joint FAO/WHO expert consultation on guidelines for the evaluation of probiotics in food. London, Ontario, Canada: World Health Organization and Food Agriculture Organization of the United Nations; 2002.
11. Sreeja V, Prajapati JB. Probiotic formulations: Application and status as pharmaceuticals-A review. Probiotics Antimicro Proteins 2013;2:81-91.
12. Arora M, Sharma S, Baldi A. Comparative insight of regulatory guidelines for probiotics in USA, India and Malaysia: A critical review. Int J Biotechnol Wellness Ind 2013;2:51-64.
13. Amagase H. Current marketplace for probiotics: A Japanese perspective. Clin Infect Dis 2008;46:S73-5.
14. Bailey R. International Nutraceutical and Functional Food Updates: Japan. Nutraceutical Funct Foods Div 2005;3-4.
15. Ohama H, Ikeda H, Moriyama H. Health foods and foods with health claims in Japan. Toxicology 2006;221:95-111.
16. Bailey R. Functional Foods in Japan: FOSHU ("Foods for Specifed Health Uses") and "Foods with Nutrient Function Claims". In: Hasler CM, Editor. Regulation of functional foods and nutraceuticals: A global perspective. Ames: Blackwell Publishing; 2005. p. 247-62.
17. MHLW. Ministry of Health, Labour and Welfare: Food for Specified Health Uses (FOSHU). Available from: http://www.mhlw.go.jp/english/topics/foodsafety/fhc/02.html. [Last retrieved on 2007 Oct 17].
18. Stanton C, Gardiner G, Meehan H, Collins K, Fitzgerald G, Lynch PB, et al. Market potential for probiotics. Am J Clin Nutr 2001;73:476-83S.
19. Leushner R, Robinson T, Hugas M, Cocconcelli P, Forget F, Klein G et al. Qualified Presumption of Safety (QPS): A generic risk assessment approach for biological agents notified to the European Food Safety Authority (EFSA). Trends Food Sci Technol 2010;21:425-35.
20. Herody C, Soueux Y, Beeh Hanson E, Gillies K. Legal status of microbial food cultures in the European union: An overview. Eur Food Feed Law Review 2010;5:258-69.
21. Narayanan R. Current legislations on probiotic products. J Agric Sci 2013;1:18-24.
22. Coppens P, da Silva MF, Pettman S. European regulations on nutraceuticals, dietary supplements and functional foods: A framework based on safety. Toxicology 2006;221:59-74.
23. Hilliam M. Functional foods in Europe. World Ingred 1998;7:40-5.
24. Patel D, Dufour Y, Domigan N. Functional food and nutraceutical registration process in japan and china: A diffusion of innovation perspective. J Pharm Pharm Sci 2008;11:1-11.
25. Yang Y. Scientific Substantiation of functional food health claims in China. J Nutr 2008;138:1199-205S.
26. Nutraceuticals in Latin America: Brazil and Beyond at Latin America: Nutraceutical Boom or Bust? Available from: http://www.nutraceuticalsworld.com/articles/2008/11/latin-america [Last accessed on 2013 Jul 26].
27. Food Standards Australia New Zealand. Health and related claims. Available from: http://www.foodstandards.gov.au [Last accessed on 2013 Jul 13].
28. Williams P, Yeatman H, Ridges L, Houston A, Rafferty J, Ridges A, et al. Nutrition function, health and related claims on packaged Australian food products-Prevalence and compliance with regulations. Asia Pac J Clin Nutr 2006;15:10-20.
29. Kaushik D, Kaushik N. Functional food/Nutraceuticals regulation in India. Pharm Rev 2009;7.
30. Food and Drug Administration. Overview of dietary supplements. Available from: http://www.fda.gov/%20Food/DietarySupplements/ConsumerInformation/ucm110417.htm [Last accessed on 2013 Aug 03].
31. Food and Drug Administration. Federal Food, Drug, and Cosmetic Act (FD and C Act). 21 U.S.C. 321. Sect 201 (2004). Available from: http: www.fda.gov/regulatoryinformation/legislation federalfooddrugandcosmeticactfdcact/default. htm[Last accessed on Jun 6].
32. Food and Drug Administration. Development and approval process (drugs). Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htm [Last accessed on 2013 Aug 30].
33. Food and Drug Administration. Guidance for Industry: CGMP for Phase 1 Investigational Drugs, July 2008. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070273.htm [Last accessed 2012 Nov 28].
34. Aggarwal A, Nagori BP, Mathur V. Regulatory approval of probiotics in US, Japan and India: A comparative study. Int J Sci Pharm Edu Res 2012;2:78-86.
35. Sharma S, Arora M, Baldi A. Probiotics in India: Current status and future prospects. Pharmaspire 2013;1-11.
36. Guidelines for evaluation of probiotics in food. Report of a Joint ICMR/DBT 2011. Available from: http://icmr.nic.in/guide/PROBIOTICS-GUIDELINES.pdf [Last accessed on 2012 Nov 28].
37. Stanton, Emms and Sia. Malaysia's markets for functional foods, nutraceuticals and organic foods: An introduction for Canadian producers and exporters. March 2011. Available from: http://www.ats-sea.agr.gc.ca/ase/pdf/5842-eng.pdf [Last accessed on 2013 Jan 28].
38. Canada Gazette, Part II: Official Regulations 2011;145, Registration SOR/2011-28 Food and Drugs Act Regulations Amending the Food and Drug Regulations (1220-Enhanced Labeling for Food Allergen and Gluten Sources and Added Sulphites) P. C. 2011-80 February 3, 2011.
39. FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. Available from: http://www.who.int/foodsafety/fs-management/en/probiotic-guidelines.pdf. [Last accessed on 2014 Nov 13].
40. Saxelin M. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: A European perspective. Clin Infect Dis 2008;46:S76-9.
41. State Food and Drug Administration. The guideline of registration for functional food. 2005. Available from: http://www.sfda.gov.cn/syjz0461/syjz0461.htm [Last accessed on 2013 Jul 28].
42. Dengan FH. The US Food and Drug Administration and probiotics: Regulatory categorization. Clin Infect Dis 2008;46:S133-6.
43. Dengan FH. Clinical studies involving probiotics: When FDA's investigational new drug rubric applies-and when it may not. Gut Microbes 2012;3:485-9.
44. U.S.C. 321(g)(1)(B) Exempting "food" bearing a structure/function claim from part of the "drug" definition and 343(r) (6) [exempting a "dietary supplement" bearing a structure or function claim from the definition of "drug"]. Available from: http://www.epw.senate.gov/FDA-001.pdf. [Last accessed on 2014 Dec 28].
45. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule. Fed Regist 2000;65:1000-50.